Search Within

Isabelle C Riviere

  1. "Roisin O'Cearbhaill"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. GDMT, Medicine (10)
  4. Gynecologic Medicine Service (10)
  5. Gynecology Disease Management Team (10)
  6. Hematologic Malignancies, Division of (10)

More Groups

People
  1. Roisin O'Cearbhaill (10)
  2. Renier Brentjens (8)
  3. Prasad Adusumilli (7)
  4. Claudia Diamonte (6)
  5. Elizabeth Halton (6)
  6. Michel Sadelain (6)

More People

Years
  1. 2023 (1)
  2. 2021 (3)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (3)
Publications
  1. Molecular Therapy (2)
  2. Molecular Therapy - Methods & Clinical Development (2)
  3. Annals of Oncology (1)
  4. Blood (1)
  5. Cancer Discovery (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (1)
  4. American Society of Hematology (1)
  5. Elsevier Inc. (1)
  6. Oxford University Press (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
    Journal Article

    Cornetta, K.; Yao, J.; House, K.; Duffy, L.; Adusumilli, P. S.; Beyer, R.; Booth, C.; Brenner, M.; Curran, K.; Grilley, B.; more...
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Screening clinical cell products for replication competent retrovirus: The National Gene Vector Biorepository experience
    Journal Article

    Cornetta, K.; Duffy, L.; Feldman, S. A.; Mackall, C. L.; Davila, M. L.; Curran, K. J.; Junghans, R. P.; Tang, J. Y.; Kochenderfer, J. N.; O'Cearbhaill, R.; more...
    Molecular Therapy - Methods & Clinical Development (2018)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy - A preliminary report
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M.; Rusch, V.; O'Cearbhaill, R.; Ngai, D.; Chintala, N.; Halton, E.; Diamonte, C.; Modi, S.; Solomon, S.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save